Although the increasing incidence of Type 2 diabetes among younger people is troubling, it remains a condition that is associated with aging. And it appears that by focusing on the sources of aging, researchers may develop a new treatment for Type 2 diabetes in the near future.
Last year, it was big news when resveratrol, a substance found in red wine, was found to counteract the effects of obesity and delay signs of aging in mice (read more in this Washington Post article). Just last week, Sirtris Pharmaceuticals of Cambridge, Massachusetts, announced that it had developed drugs much more potent than resveratrol that have a similar effect on the genes that control aging. Furthermore, the drugs have been shown to reduce insulin resistance in mice and rats, so the company intends to test and market the drugs as a treatment for Type 2 diabetes. Read the full story at MedlinePlus.
(As a side note, we find it amusing that an article on treating the genetic causes of Type 2 diabetes also flatly states that it “comes from too little exercise and a poor diet.” At least the article was corrected to address an even greater error; we were surprised to read in the previous version that drugs were being developed to “reduce insulin sensitivity”!)
This blog entry was written by Editorial Assistant Quinn Phillips.